S&P 500   4,397.94 (-1.89%)
DOW   34,265.37 (-1.30%)
QQQ   351.69 (-2.77%)
AAPL   162.41 (-1.28%)
MSFT   296.03 (-1.85%)
FB   303.17 (-4.23%)
GOOGL   2,607.03 (-2.22%)
AMZN   2,852.86 (-5.95%)
TSLA   943.90 (-5.26%)
NVDA   233.74 (-3.21%)
BABA   123.23 (-5.95%)
NIO   27.35 (-6.11%)
AMD   118.81 (-2.53%)
CGC   7.29 (-3.57%)
MU   81.93 (-3.69%)
GE   96.30 (-1.98%)
T   26.61 (-1.52%)
F   20.65 (-4.62%)
DIS   137.38 (-6.94%)
AMC   17.97 (-0.55%)
PFE   52.79 (-2.33%)
ACB   4.46 (-6.11%)
BA   205.44 (-4.09%)
S&P 500   4,397.94 (-1.89%)
DOW   34,265.37 (-1.30%)
QQQ   351.69 (-2.77%)
AAPL   162.41 (-1.28%)
MSFT   296.03 (-1.85%)
FB   303.17 (-4.23%)
GOOGL   2,607.03 (-2.22%)
AMZN   2,852.86 (-5.95%)
TSLA   943.90 (-5.26%)
NVDA   233.74 (-3.21%)
BABA   123.23 (-5.95%)
NIO   27.35 (-6.11%)
AMD   118.81 (-2.53%)
CGC   7.29 (-3.57%)
MU   81.93 (-3.69%)
GE   96.30 (-1.98%)
T   26.61 (-1.52%)
F   20.65 (-4.62%)
DIS   137.38 (-6.94%)
AMC   17.97 (-0.55%)
PFE   52.79 (-2.33%)
ACB   4.46 (-6.11%)
BA   205.44 (-4.09%)
S&P 500   4,397.94 (-1.89%)
DOW   34,265.37 (-1.30%)
QQQ   351.69 (-2.77%)
AAPL   162.41 (-1.28%)
MSFT   296.03 (-1.85%)
FB   303.17 (-4.23%)
GOOGL   2,607.03 (-2.22%)
AMZN   2,852.86 (-5.95%)
TSLA   943.90 (-5.26%)
NVDA   233.74 (-3.21%)
BABA   123.23 (-5.95%)
NIO   27.35 (-6.11%)
AMD   118.81 (-2.53%)
CGC   7.29 (-3.57%)
MU   81.93 (-3.69%)
GE   96.30 (-1.98%)
T   26.61 (-1.52%)
F   20.65 (-4.62%)
DIS   137.38 (-6.94%)
AMC   17.97 (-0.55%)
PFE   52.79 (-2.33%)
ACB   4.46 (-6.11%)
BA   205.44 (-4.09%)
S&P 500   4,397.94 (-1.89%)
DOW   34,265.37 (-1.30%)
QQQ   351.69 (-2.77%)
AAPL   162.41 (-1.28%)
MSFT   296.03 (-1.85%)
FB   303.17 (-4.23%)
GOOGL   2,607.03 (-2.22%)
AMZN   2,852.86 (-5.95%)
TSLA   943.90 (-5.26%)
NVDA   233.74 (-3.21%)
BABA   123.23 (-5.95%)
NIO   27.35 (-6.11%)
AMD   118.81 (-2.53%)
CGC   7.29 (-3.57%)
MU   81.93 (-3.69%)
GE   96.30 (-1.98%)
T   26.61 (-1.52%)
F   20.65 (-4.62%)
DIS   137.38 (-6.94%)
AMC   17.97 (-0.55%)
PFE   52.79 (-2.33%)
ACB   4.46 (-6.11%)
BA   205.44 (-4.09%)
OTCMKTS:OPHLF

Ono Pharmaceutical Stock Forecast, Price & News

$24.62
0.00 (0.00%)
(As of 01/21/2022 12:00 AM ET)
Add
Compare
Today's Range
$24.62
$24.62
50-Day Range
$20.57
$25.04
52-Week Range
$20.57
$29.70
Volume
N/A
Average Volume
150 shs
Market Capitalization
$12.66 billion
P/E Ratio
16.20
Dividend Yield
N/A
Beta
0.34
30 days | 90 days | 365 days | Advanced Chart
Receive OPHLF News and Ratings via Email

Sign-up to receive the latest news and ratings for Ono Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter.


Ono Pharmaceutical logo

About Ono Pharmaceutical

Ono Pharmaceutical Co., Ltd. engages in the production, purchase, and sale of internal medicine, patch and injectable medicine. The company was founded by Ichibei Fushimiya in 1717 and is headquartered in Osaka, Japan.

Headlines

Ono Pharmaceutical Co. Ltd (OPHLF)
January 7, 2022 |  nasdaq.com
Here's what Wall Street expects from Ono Pharmaceutical's earnings
November 13, 2021 |  markets.businessinsider.com
Here's what to expect from Ono Pharmaceutical's earnings
January 31, 2021 |  markets.businessinsider.com
News for Ono Pharmaceutical
December 26, 2020 |  markets.businessinsider.com
Fate Therapeutics Jumped On Supportive Trial Data
December 18, 2020 |  seekingalpha.com
Gilead's Cancer Follies
October 2, 2020 |  seekingalpha.com
Ono Pharmaceutical Co., Ltd. (OPHLF)
August 16, 2020 |  ca.finance.yahoo.com
Ono Pharmaceutical Co Ltd (Japan) (OPHLF)
August 2, 2020 |  www.nasdaq.com
Ono Pharmaceutical Co Ltd (Japan) (OPHLF) Short Interest
September 28, 2019 |  www.nasdaq.com
See More Headlines

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:OPHLF
Employees
3,607
Year Founded
N/A

Sales & Book Value

Annual Sales
$2.92 billion
Cash Flow
$1.32 per share
Book Value
$10.16 per share

Profitability

Net Income
$708.99 million
Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
$12.66 billion
Optionable
Not Optionable

Company Calendar

Today
1/21/2022
Fiscal Year End
3/31/2022

MarketRank

Overall MarketRank

1.30 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 2.5 5 -4 -3 -2 -1 -












Ono Pharmaceutical (OTCMKTS:OPHLF) Frequently Asked Questions

How has Ono Pharmaceutical's stock price been impacted by COVID-19?

Ono Pharmaceutical's stock was trading at $22.00 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, OPHLF shares have increased by 11.9% and is now trading at $24.62.
View which stocks have been most impacted by COVID-19
.

Who are Ono Pharmaceutical's key executives?

Ono Pharmaceutical's management team includes the following people:
  • Gyo Sagara, President & Representative Director
  • Toichi Takino, Managing Executive Officer & GM-Research
  • Shozo Matsuoka, Executive Officer & Manager-NV Strategy Planning
  • Isao Ono, Director & Managing Executive Officer
  • Kei Sano, Director & Senior Managing Executive Officer

What is Ono Pharmaceutical's stock symbol?

Ono Pharmaceutical trades on the OTCMKTS under the ticker symbol "OPHLF."

How do I buy shares of Ono Pharmaceutical?

Shares of OPHLF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Ono Pharmaceutical's stock price today?

One share of OPHLF stock can currently be purchased for approximately $24.62.

How much money does Ono Pharmaceutical make?

Ono Pharmaceutical has a market capitalization of $12.66 billion and generates $2.92 billion in revenue each year. The company earns $708.99 million in net income (profit) each year or $1.52 on an earnings per share basis.

How many employees does Ono Pharmaceutical have?

Ono Pharmaceutical employs 3,607 workers across the globe.

What is Ono Pharmaceutical's official website?

The official website for Ono Pharmaceutical is www.ono.co.jp.

Where are Ono Pharmaceutical's headquarters?

Ono Pharmaceutical is headquartered at 8-2 Kyutaromachi 1-chome Chuo-ku, Osaka M0, 541-8564.

How can I contact Ono Pharmaceutical?

Ono Pharmaceutical's mailing address is 8-2 Kyutaromachi 1-chome Chuo-ku, Osaka M0, 541-8564. The company can be reached via phone at (166) 263-5670 or via fax at 816-6263-2950.


This page was last updated on 1/21/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.